| SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT |
SCHEDULE
OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT
| |
|
Healthcare
IT |
|
|
Medical
Practice Management
|
|
|
Unallocated
Corporate Expenses
|
|
|
Total |
|
| |
|
Year
Ended December 31, 2022 |
|
| |
|
($
in thousands) |
|
| |
|
Healthcare
IT |
|
|
Medical
Practice Management
|
|
|
Unallocated
Corporate Expenses
|
|
|
Total |
|
| Net
revenue |
|
$ |
125,276 |
|
|
$ |
13,550 |
|
|
$ |
- |
|
|
$ |
138,826 |
|
| Operating
expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Direct
operating costs |
|
|
73,702 |
|
|
|
10,732 |
|
|
|
- |
|
|
|
84,434 |
|
| Selling
and marketing |
|
|
9,760 |
|
|
|
28 |
|
|
|
- |
|
|
|
9,788 |
|
| General
and administrative |
|
|
12,558 |
|
|
|
1,802 |
|
|
|
9,460 |
|
|
|
23,820 |
|
| Research
and development |
|
|
4,401 |
|
|
|
- |
|
|
|
- |
|
|
|
4,401 |
|
| Change
in contingent consideration |
|
|
(3,090 |
) |
|
|
- |
|
|
|
- |
|
|
|
(3,090 |
) |
| Depreciation
and amortization |
|
|
11,368 |
|
|
|
357 |
|
|
|
- |
|
|
|
11,725 |
|
| Net
loss on lease termination and unoccupied lease charges |
|
|
1,138 |
|
|
|
- |
|
|
|
- |
|
|
|
1,138 |
|
| Total
operating expenses |
|
|
109,837 |
|
|
|
12,919 |
|
|
|
9,460 |
|
|
|
132,216 |
|
| Operating
income (loss) |
|
$ |
15,439 |
|
|
$ |
631 |
|
|
$ |
(9,460 |
) |
|
$ |
6,610 |
|
| |
|
Healthcare IT |
|
|
Medical Practice
Management
|
|
|
Unallocated
Corporate
Expenses
|
|
|
Total |
|
| |
|
Year Ended December 31, 2021 |
|
| |
|
($ in thousands) |
|
| |
|
Healthcare IT |
|
|
Medical Practice
Management
|
|
|
Unallocated
Corporate
Expenses
|
|
|
Total |
|
| Net revenue |
|
$ |
127,080 |
|
|
$ |
12,519 |
|
|
$ |
- |
|
|
$ |
139,599 |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Direct operating costs |
|
|
76,981 |
|
|
|
9,937 |
|
|
|
- |
|
|
|
86,918 |
|
| Selling and marketing |
|
|
8,755 |
|
|
|
31 |
|
|
|
- |
|
|
|
8,786 |
|
| General and administrative |
|
|
13,910 |
|
|
|
2,080 |
|
|
|
8,283 |
|
|
|
24,273 |
|
| Research and development |
|
|
4,408 |
|
|
|
- |
|
|
|
- |
|
|
|
4,408 |
|
| Change in contingent consideration |
|
|
(2,515 |
) |
|
|
- |
|
|
|
- |
|
|
|
(2,515 |
) |
| Depreciation and amortization |
|
|
11,854 |
|
|
|
341 |
|
|
|
- |
|
|
|
12,195 |
|
| Net loss on lease termination, impairment and unoccupied lease charges |
|
|
2,005 |
|
|
|
- |
|
|
|
- |
|
|
|
2,005 |
|
| Total operating expenses |
|
|
115,398 |
|
|
|
12,389 |
|
|
|
8,283 |
|
|
|
136,070 |
|
| Operating income (loss) |
|
$ |
11,682 |
|
|
$ |
130 |
|
|
$ |
(8,283 |
) |
|
$ |
3,529 |
|
|